Evolent Health, Inc.
EVH
$2.99
-$0.07-2.29%
NYSE
| 12/31/2025 | 09/30/2025 | 06/30/2025 | 03/31/2025 | 12/31/2024 | |
|---|---|---|---|---|---|
| Net Income | -534.51M | -128.18M | -130.45M | -108.96M | -61.62M |
| Total Depreciation and Amortization | 92.65M | 54.71M | 60.10M | 65.73M | 71.17M |
| Total Amortization of Deferred Charges | 37.80M | 36.36M | 33.69M | 34.25M | 33.95M |
| Total Other Non-Cash Items | 500.29M | 140.05M | 138.02M | 128.67M | 91.83M |
| Change in Net Operating Assets | -57.38M | -139.13M | -134.68M | -101.26M | -116.56M |
| Cash from Operations | 38.84M | -36.19M | -33.33M | 18.42M | 18.77M |
| Capital Expenditure | -34.09M | -79.80M | -88.13M | -39.48M | -33.12M |
| Sale of Property, Plant, and Equipment | 91.31M | -- | -- | -- | -- |
| Cash Acquisitions | -57.44M | -19.50M | -19.50M | -19.50M | -19.50M |
| Divestitures | -- | -- | -- | -- | -- |
| Other Investing Activities | -14.00K | -3.02M | -5.65M | -7.31M | -10.31M |
| Cash from Investing | -233.00K | -102.32M | -113.28M | -66.29M | -62.93M |
| Total Debt Issued | 408.05M | 448.32M | 279.58M | 279.58M | 58.58M |
| Total Debt Repaid | -342.98M | -228.73M | -61.97M | -61.97M | 0.00 |
| Issuance of Common Stock | -- | -- | 2.34M | 2.40M | 3.46M |
| Repurchase of Common Stock | -45.22M | -45.47M | -5.62M | -5.96M | -15.70M |
| Issuance of Preferred Stock | -- | -- | -- | -- | -- |
| Repurchase of Preferred Stock | -- | -- | -- | -- | -- |
| Total Dividends Paid | -11.13M | -15.93M | -19.14M | -19.58M | -20.09M |
| Other Financing Activities | -44.64M | -4.13M | -8.33M | -102.06M | -26.82M |
| Cash from Financing | -35.92M | 154.05M | 186.86M | 92.41M | -565.00K |
| Foreign Exchange rate Adjustments | -486.00K | -397.00K | -227.00K | -168.00K | -229.00K |
| Miscellaneous Cash Flow Adjustments | -- | -- | -- | -- | -- |
| Net Change in Cash | 2.20M | 15.15M | 40.02M | 44.37M | -44.96M |